GU Cancers 2019 | Histo-Genetic risk classification in renal cell carcinoma

Cedric Lebacle • 15 Feb 2019

GU Cancers 2019

Cedric Lebacle, of the University of Paris-Sud, Orsay, France, speaks at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA, and discusses the implementation of cytogenetic parameters to clinical and pathological parameters to better predict high-risk patients.

Transcript (edited for clarity)

the UAGRC. The setting of this study is about recurrence for high-risk patient. The classification nowadays based on clinical and pathological features still misclassify patients, and no is approved for high-risk patient, for adjuvant treatment, but we don’t know which patient really could benefit of this treatment. So that’s why implemented cytogenetic parameters to clinical and pathological parameters to better predict high-risk patients.